CDK2 and cervical carcinoma: These results strongly suggested that GDF15 accelerated cell cycle progression in cervical cancer cells by targeting cdc25A, CDK2, CDK4, p21, CyclinD1 and CyclinE1 through alterations in the expression of FOXO1 and C-myc.